KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bionano Genomics (BNGO) Net Income (2017 - 2025)

Historic Net Income for Bionano Genomics (BNGO) over the last 9 years, with Q3 2025 value amounting to -$8.5 million.

  • Bionano Genomics' Net Income rose 8078.24% to -$8.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.6 million, marking a year-over-year increase of 7158.19%. This contributed to the annual value of -$112.0 million for FY2024, which is 5181.92% up from last year.
  • Per Bionano Genomics' latest filing, its Net Income stood at -$8.5 million for Q3 2025, which was up 8078.24% from -$6.9 million recorded in Q2 2025.
  • In the past 5 years, Bionano Genomics' Net Income ranged from a high of -$3.1 million in Q1 2025 and a low of -$112.6 million during Q3 2023
  • Over the past 5 years, Bionano Genomics' median Net Income value was -$30.0 million (recorded in 2022), while the average stood at -$29.9 million.
  • In the last 5 years, Bionano Genomics' Net Income plummeted by 25388.1% in 2023 and then skyrocketed by 9012.79% in 2025.
  • Bionano Genomics' Net Income (Quarter) stood at -$22.9 million in 2021, then crashed by 68.53% to -$38.7 million in 2022, then decreased by 13.48% to -$43.9 million in 2023, then surged by 54.15% to -$20.1 million in 2024, then soared by 57.75% to -$8.5 million in 2025.
  • Its Net Income stands at -$8.5 million for Q3 2025, versus -$6.9 million for Q2 2025 and -$3.1 million for Q1 2025.